Odra, świnka i różyczka
Leczenie
Szczepionka MMR, zawierająca żywe, atenuowane wirusy odry, świnki i różyczki, jest podawana podskórnie w dwóch dawkach: pierwsza w wieku 12-15 miesięcy, druga w 4-6 lat. U dorosłych bez potwierdzonej odporności zaleca się co najmniej jedną dawkę, a w grupach ryzyka – dwie dawki w odstępie minimum 28 dni. Skuteczność jednej dawki wynosi około 93% przeciw odrze, 72% przeciw śwince i 97% przeciw różyczce, natomiast dwie dawki zwiększają ochronę do 97%, 86% i 99% odpowiednio. Szczepionka jest przeciwwskazana u kobiet w ciąży, osób z ciężkimi zaburzeniami odporności, ostrą chorobą gorączkową, ciężką reakcją alergiczną na składniki szczepionki oraz nieleczoną aktywną gruźlicą. Profilaktyka poekspozycyjna jest skuteczna, jeśli szczepienie nastąpi w ciągu 72 godzin od kontaktu z chorym na odrę lub świnkę.
- Charakterystyka szczepionki MMR (odra, świnka i różyczka)
- Wskazania i przeciwwskazania do szczepienia MMR
- Zastosowanie szczepionki MMR w profilaktyce chorób zakaźnych
- Profilaktyka odry
- Profilaktyka świnki
- Profilaktyka różyczki
- Zastosowanie w profilaktyce poekspozycyjnej
- Działania niepożądane po szczepieniu MMR
- Zastosowanie terapeutyczne szczepionki MMR
- Stosowanie szczepionki MMR w szczególnych sytuacjach epidemiologicznych
- Leczenie chorób zapobieganych szczepionką MMR
- Znaczenie szczepionki MMR dla zdrowia publicznego
Charakterystyka szczepionki MMR (odra, świnka i różyczka)
Szczepionka MMR (Measles, Mumps, Rubella) jest skojarzoną szczepionką zawierającą żywe, atenuowane (osłabione) wirusy odry, świnki i różyczki, która zapewnia ochronę przed tymi trzema chorobami zakaźnymi. Szczepionka została pierwotnie wprowadzona w 1971 roku i od tego czasu podano ją setkom milionów osób na całym świecie, potwierdzając jej skuteczność i bezpieczeństwo.12
Szczepionka MMR jest podawana w postaci wstrzyknięcia podskórnego, najczęściej w ramię lub udo. Stymuluje ona układ odpornościowy do wytworzenia przeciwciał przeciwko wirusom odry, świnki i różyczki, co zapewnia długotrwałą ochronę przed tymi chorobami, niekiedy na całe życie.34
Schemat podawania szczepionki MMR
Standardowy schemat szczepienia MMR obejmuje dwie dawki:56
- Pierwsza dawka podawana jest dzieciom w wieku 12-15 miesięcy
- Druga dawka podawana jest dzieciom w wieku 4-6 lat
W przypadku osób dorosłych urodzonych po 1956/1957 roku, które nie mają potwierdzonej odporności lub historii szczepień, zaleca się przyjęcie co najmniej jednej dawki szczepionki MMR.7 Osoby z grup zwiększonego ryzyka, takie jak pracownicy służby zdrowia, studenci czy osoby planujące podróże zagraniczne, powinny otrzymać dwie dawki szczepionki w odstępie co najmniej 28 dni.8
W niektórych sytuacjach epidemiologicznych lub przy podróżach do obszarów o wysokim ryzyku zakażenia, szczepionka może być podana także niemowlętom od 6 miesiąca życia, jednak nie zastępuje to standardowych dawek podawanych po 12 miesiącu życia.910
Skuteczność szczepionki MMR
Szczepionka MMR wykazuje wysoką skuteczność w zapobieganiu trzem chorobom:1112
- Jedna dawka szczepionki MMR zapewnia około 93% skuteczności przeciwko odrze, 72% przeciwko śwince i 97% przeciwko różyczce
- Dwie dawki szczepionki MMR zapewniają około 97% skuteczności przeciwko odrze i 86% przeciwko śwince oraz 99% przeciwko różyczce
Dla większości osób szczepionka MMR zapewnia długotrwałą ochronę, często na całe życie, szczególnie przed odrą i różyczką. W przypadku świnki odporność może z czasem zmniejszać się u niektórych osób.1314
Wskazania i przeciwwskazania do szczepienia MMR
Szczepionka MMR jest zalecana dla wszystkich dzieci w ramach rutynowego kalendarza szczepień, a także dla osób dorosłych, które nie były wcześniej zaszczepione lub nie mają potwierdzonej odporności na odrę, świnkę i różyczkę.1516
Szczególne grupy, dla których szczepionka jest zalecana:
- Pracownicy służby zdrowia mający bezpośredni kontakt z pacjentami17
- Osoby podróżujące za granicę, szczególnie do obszarów o zwiększonym ryzyku występowania odry18
- Studenci i osoby mieszkające w warunkach zbiorowego zakwaterowania19
- Kobiety w wieku rozrodczym, które planują ciążę (szczepienie powinno być wykonane przynajmniej miesiąc przed zajściem w ciążę)20
- Osoby po ekspozycji na zachorowanie (jako profilaktyka poekspozycyjna, najlepiej w ciągu 72 godzin od kontaktu)21
Przeciwwskazania do szczepienia MMR:
- Ciąża – kobiety w ciąży nie powinny otrzymywać szczepionki MMR ze względu na teoretyczne ryzyko dla płodu (zaleca się unikanie zajścia w ciążę przez 4 tygodnie po szczepieniu)2223
- Ciężkie zaburzenia odporności wynikające z choroby lub leczenia immunosupresyjnego24
- Ostra choroba gorączkowa (szczepienie należy odroczyć do ustąpienia objawów)25
- Ciężka reakcja alergiczna (anafilaktyczna) po poprzedniej dawce szczepionki MMR lub na jakikolwiek składnik szczepionki, w tym żelatynę lub neomycynę26
- Nieleczona aktywna gruźlica27
Należy podkreślić, że łagodne choroby, takie jak przeziębienie bez wysokiej gorączki, nie są przeciwwskazaniem do szczepienia MMR.28 Osoby z alergią na jaja mogą bezpiecznie otrzymać szczepionkę MMR, ponieważ zawiera ona jedynie śladowe ilości białka jaja, niewystarczające do wywołania reakcji alergicznej.2930
Zastosowanie szczepionki MMR w profilaktyce chorób zakaźnych
Szczepionka MMR stanowi podstawową metodę profilaktyki trzech potencjalnie poważnych chorób zakaźnych: odry, świnki i różyczki. Jej powszechne stosowanie znacząco zmniejszyło liczbę zachorowań na te choroby w wielu krajach.31
Profilaktyka odry
Odra jest wysoce zakaźną chorobą wirusową, która przed wprowadzeniem szczepionki powodowała ok. 2,6 miliona zgonów rocznie na świecie. Dzięki szczepieniom liczba ta spadła do około 122 000 zgonów rocznie (dane z 2012 r.).32 Szczepionka MMR chroni przed charakterystyczną wysypką i wysoką gorączką związaną z odrą, a także przed poważnymi powikłaniami, takimi jak zapalenie mózgu.33
Profilaktyka świnki
Świnka (nagminne zapalenie przyusznic) może prowadzić do bolesnego obrzęku ślinianek pod uszami lub szczęką, gorączki oraz potencjalnie poważnych powikłań, jak zapalenie jąder, jajników lub opon mózgowo-rdzeniowych. Szczepionka MMR znacząco ogranicza ryzyko zachorowania i związanych z nim powikłań.3435
Profilaktyka różyczki
Różyczka (tzw. różyczka niemiecka) może powodować wysypkę i gorączkę, ale szczególnie niebezpieczna jest dla kobiet w ciąży, gdyż zakażenie w tym okresie może prowadzić do poważnych wad wrodzonych u płodu (zespół różyczki wrodzonej). Szczepienie MMR zapobiega tym zagrożeniom i chroni zarówno osoby szczepione, jak i nieszczepione poprzez zapobieganie krążeniu wirusa w populacji.3637
Zastosowanie w profilaktyce poekspozycyjnej
Szczepionka MMR może być stosowana jako profilaktyka poekspozycyjna u osób, które miały kontakt z chorymi na odrę lub świnkę. Podana w ciągu 72 godzin od kontaktu z chorym na odrę, może zapobiec zachorowaniu lub złagodzić jego przebieg.3839 Skuteczność profilaktyki poekspozycyjnej zmniejsza się wraz z upływem czasu od ekspozycji.
Działania niepożądane po szczepieniu MMR
Szczepionka MMR jest uważana za bardzo bezpieczną, a większość osób nie doświadcza żadnych istotnych działań niepożądanych po jej podaniu. Występujące działania niepożądane są zazwyczaj łagodne i przejściowe.4041
Częste łagodne działania niepożądane:
- Ból, zaczerwienienie lub obrzęk w miejscu wstrzyknięcia4243
- Gorączka (1-3 dni), która może wystąpić 7-12 dni po szczepieniu44
- Łagodna wysypka przypominająca odrę (nieinfekacyjna)45
- Przejściowy obrzęk ślinianek46
- Przejściowy ból stawów (częściej u nastolatków i dorosłych kobiet)4748
Rzadkie poważniejsze działania niepożądane:
- Drgawki gorączkowe (około 1 na 3000-4000 dzieci, zwykle 6-14 dni po szczepieniu)4950
- Przejściowe obniżenie liczby płytek krwi (małopłytkowość), które może powodować nietypowe krwawienia lub siniaki (około 1 na 30 000 osób)5152
- Ciężkie reakcje alergiczne (anafilaksja) – niezwykle rzadkie, występują u około 1 osoby na 1-14 milionów podanych dawek53
W wyjątkowo rzadkich przypadkach (około 1 na 500 000 lub więcej dawek) szczepionka MMR może być związana z zapaleniem mózgu.54 Warto jednak podkreślić, że ryzyko wystąpienia poważnych powikłań po naturalnym zakażeniu odrą, świnką lub różyczką jest znacznie większe niż ryzyko związane ze szczepieniem.5556
Zastosowanie terapeutyczne szczepionki MMR
Chociaż szczepionka MMR jest przede wszystkim stosowana w celach profilaktycznych, istnieją pewne nietypowe zastosowania terapeutyczne tej szczepionki w medycynie.
Leczenie brodawek skórnych
Badania kliniczne wykazały, że szczepionka MMR może być stosowana w immunoterapii opornych na leczenie brodawek skórnych, w tym brodawek podpaznokciowych. Mechanizm działania opiera się na stymulacji układu odpornościowego, co prowadzi do reakcji przeciwko wirusowi brodawczaka ludzkiego (HPV) odpowiedzialnemu za brodawki.57
W tej metodzie szczepionkę MMR podaje się bezpośrednio (śródzmianowo) do brodawki. Skuteczność leczenia waha się od 27% do 81%, a pacjenci zazwyczaj wymagają średnio 3-5 sesji terapeutycznych w odstępach 2-tygodniowych.5859 Efekt terapeutyczny może obejmować również brodawki w innych lokalizacjach, co sugeruje systemowe działanie immunomodulujące.
Leczenie mięczaka zakaźnego
Podobnie jak w przypadku brodawek, szczepionka MMR znalazła zastosowanie w leczeniu opornych na standardową terapię przypadków mięczaka zakaźnego (molluscum contagiosum). W badaniach porównawczych wykazano, że śródzmianowe podanie szczepionki MMR może prowadzić do całkowitego ustąpienia zmian u 73-80% pacjentów.6061
Ta metoda leczenia jest szczególnie wartościowa ze względu na korzystny profil bezpieczeństwa, efektywność kosztową oraz brak poważnych działań niepożądanych. Najczęstsze efekty uboczne obejmują ból w miejscu wstrzyknięcia oraz objawy przypominające łagodną grypę.62
Stosowanie szczepionki MMR w szczególnych sytuacjach epidemiologicznych
W przypadku wystąpienia ognisk epidemicznych odry lub świnki, zalecenia dotyczące stosowania szczepionki MMR mogą zostać zmodyfikowane, aby ograniczyć rozprzestrzenianie się choroby.63
Postępowanie w ognisku epidemicznym odry
Podczas ogniska epidemicznego odry zaleca się:6465
- Przyspieszenie podania pierwszej i/lub drugiej dawki szczepionki MMR dzieciom mieszkającym lub podróżującym do obszarów z ogniskiem odry
- Podanie szczepionki dzieciom w wieku od 6 miesięcy do 12 miesięcy (ta dawka nie jest wliczana do rutynowego schematu szczepień i dzieci nadal wymagają dwóch standardowych dawek po ukończeniu 12 miesięcy)
- Podanie szczepionki MMR osobom, które miały kontakt z chorym na odrę, w ciągu 72 godzin od ekspozycji jako profilaktykę poekspozycyjną
- Upewnienie się, że wszyscy dorośli urodzeni po 1956/1957 roku mają udokumentowane dwie dawki szczepionki MMR lub laboratoryjne potwierdzenie odporności
Postępowanie w ognisku epidemicznym świnki
W przypadku ogniska epidemicznego świnki:6667
- Osobom z grup podwyższonego ryzyka, takim jak studenci czy osoby mieszkające w warunkach zbiorowego zakwaterowania, może być zalecana trzecia dawka szczepionki MMR
- Badania wykazały, że podanie trzeciej dawki może zmniejszyć ryzyko zachorowania na świnkę o 78,1% w porównaniu z dwiema dawkami
- Pracownikom służby zdrowia, niezależnie od roku urodzenia, zaleca się dwie dawki szczepionki MMR w przypadku braku potwierdzonej odporności na świnkę
Podczas ognisk epidemicznych szczególnie ważne jest szybkie reagowanie i zapewnienie dostępności szczepionki dla osób z grup ryzyka. Lokalne organy zdrowia publicznego często organizują dodatkowe punkty szczepień, aby ułatwić dostęp do szczepionki MMR.6869
Leczenie chorób zapobieganych szczepionką MMR
Mimo że szczepionka MMR jest najskuteczniejszą metodą zapobiegania odrze, śwince i różyczce, w przypadku zachorowania stosuje się leczenie objawowe, gdyż nie ma specyficznego leczenia przyczynowego tych chorób wirusowych.7071
Leczenie odry
Nie istnieje specyficzne leczenie przeciwwirusowe odry. Leczenie koncentruje się na łagodzeniu objawów i zapobieganiu powikłaniom:7273
- Odpoczynek i nawodnienie
- Leki przeciwgorączkowe (paracetamol, ibuprofen) w celu zmniejszenia gorączki i bólu
- Suplementacja witaminy A – zalecana przez WHO u wszystkich dzieci z ostrą odrą, niezależnie od kraju zamieszkania, aby zmniejszyć ryzyko powikłań. Dawka witaminy A zależy od wieku dziecka
- Antybiotyki – stosowane tylko w przypadku rozwinięcia powikłań bakteryjnych
Pacjenci z immunosupresją lub ciężkim przebiegiem odry mogą wymagać hospitalizacji i intensywnego leczenia podtrzymującego.74 Nie zaleca się stosowania sterydów w leczeniu odry, gdyż mogą one pogorszyć przebieg choroby u niektórych pacjentów.75
Leczenie świnki
Leczenie świnki również ma charakter objawowy:76
- Odpoczynek i nawodnienie
- Leki przeciwbólowe i przeciwgorączkowe w celu złagodzenia bólu i gorączki
- Okłady zimne lub ciepłe (w zależności od preferencji pacjenta) na obrzęknięte ślinianki
- Dieta płynna lub miękka w przypadku trudności z żuciem
- W przypadku powikłań, takich jak zapalenie jąder, może być konieczne intensywniejsze leczenie przeciwbólowe i stosowanie okładów chłodzących
Immunoglobulina (IVIG) nie jest zalecana jako profilaktyka poekspozycyjna w przypadku świnki.77
Leczenie różyczki
Różyczka zazwyczaj przebiega łagodnie i wymaga jedynie leczenia objawowego:78
- Odpoczynek
- Leki przeciwgorączkowe w przypadku gorączki
- Nawodnienie
W przypadku różyczki wrodzonej (gdy zakażenie nastąpiło podczas ciąży), metody leczenia zależą od ciężkości wad wrodzonych i mogą obejmować leczenie farmakologiczne lub chirurgiczne. W niektórych przypadkach uszkodzenia są trwałe i możliwe jest jedynie leczenie objawowe poprawiające jakość życia.79
Warto podkreślić, że najskuteczniejszą metodą walki z tymi chorobami i ich powikłaniami pozostaje profilaktyka poprzez szczepienia. Szczepionka MMR zapobiega nie tylko zachorowaniu, ale także wszystkim potencjalnym powikłaniom i eliminuje potrzebę leczenia.8081
Znaczenie szczepionki MMR dla zdrowia publicznego
Szczepionka MMR ma ogromne znaczenie dla zdrowia publicznego na całym świecie. Przed wprowadzeniem powszechnych szczepień przeciwko odrze, choroba ta powodowała około 2,6 miliona zgonów rocznie. Dzięki szczepieniom liczba ta spadła do około 122 000 zgonów w 2012 roku, głównie w krajach o niskich dochodach.82
Należy podkreślić, że szczepionka MMR nie tylko chroni osoby zaszczepione, ale również przyczynia się do ochrony zbiorowej (odporności populacyjnej). Gdy wystarczająco duża część populacji jest zaszczepiona (co najmniej 95% w przypadku odry), ogranicza to krążenie wirusa i chroni osoby, które nie mogą być zaszczepione z powodów medycznych.8384
W regionach o wysokim poziomie zaszczepienia udało się znacząco ograniczyć lub nawet całkowicie wyeliminować zachorowania na odrę, świnkę i różyczkę. Przykładowo, region Ameryk został ogłoszony wolnym od endemicznej odry w 2016 roku.85 Jednak spadek poziomu zaszczepienia poniżej 95% może prowadzić do powrotu tych chorób, co obserwowano w niektórych krajach w ostatnich latach.8687
Z tego powodu utrzymanie wysokiego poziomu zaszczepienia populacji szczepionką MMR pozostaje kluczowym elementem programów zdrowia publicznego na całym świecie, umożliwiającym kontrolę i potencjalną eliminację tych groźnych chorób zakaźnych.88
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 MMR vaccine – Wikipediahttps://en.wikipedia.org/wiki/MMR_vaccine
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles), abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection. […] The MMR vaccine is widely used around the world. As of 2012, 575 million doses had been administered since the vaccine’s introduction worldwide. Measles resulted in 2.6 million deaths per year before immunization became common. This has decreased to 122,000 deaths per year as of 2012, mostly in low-income countries. Through vaccination, as of 2018, rates of measles in North and South America are very low. Rates of disease have been seen to increase in populations that go unvaccinated. Between 2000 and 2018, vaccination decreased measles deaths by 73%.
- #2 Measles, Mumps, and Rubella Vaccines | Smithsonian Institutionhttps://www.si.edu/spotlight/antibody-initiative/mmr
One of the standard childhood vaccinations in the United States is the MMR vaccine, which produces immunity against measles, mumps, and rubella. […] In the United States, measles, mumps, and rubella are now prevented by a single combined vaccine, known as MMR (measles, mumps, rubella). The combined vaccine was developed by Dr. Maurice Hilleman in 1971. In 1979 it was modified, substituting Dr. Stanley Plotkin’s more effective rubella vaccine. […] The combined vaccine is more convenient for patients, and this convenience actually saves lives. Fewer injections translate as fewer missed doses, and therefore more protection in a shorter time. The MMR vaccine has saved millions of lives worldwide.
- #3 Measles, mumps, and rubella virus vaccine live (subcutaneous route, intramuscular route) – Mayo Clinichttps://www.mayoclinic.org/drugs-supplements/measles-mumps-and-rubella-virus-vaccine-live-subcutaneous-route-intramuscular-route/description/drg-20062140
Measles, mumps, and rubella virus vaccine (live) is an active immunizing agent that is given to protect against infections caused by measles, mumps, and rubella (German measles). It works by causing your body to produce its own protection (antibodies) against the virus. […] This vaccine is to be administered only by or under the supervision of your doctor or other health care professional. […] Use of M-M-R II is not recommended in children younger than 12 months of age. Safety and efficacy have not been established for measles vaccine in children younger than 6 months of age and for mumps and rubella vaccine in children younger than 12 months of age. […] This vaccine is given in 2 doses. First dose is given at 12 to 15 months of age, while the second dose is given at 4 to 6 years of age. If this vaccine is not given on time, 2 doses will be given at least 4 weeks apart.
- #4 Measles Vaccination | Measles (Rubeola) | CDChttps://www.cdc.gov/measles/vaccines/index.html
Two doses of the MMR vaccine are recommended by doctors as the best way to protect against measles, mumps, and rubella. […] The best way to protect against measles is to get the measles, mumps, and rubella (MMR) vaccine. […] Most people who are vaccinated with MMR MMRV will be protected for life. […] There are two vaccines that protect against measles, mumps, and rubella. […] Both MMR and MMRV vaccines may be given at the same time as other vaccines. […] Children need 2 doses of MMR vaccines: 1215 months old 1st dose 46 years old 2nd dose. […] Anyone traveling internationally should be fully vaccinated before traveling. […] If you don’t have immunity against these diseases and become exposed to them, talk with your doctor about getting MMR vaccine. […] The MMR vaccine protects your child from measles, mumps, and rubella, potentially serious diseases caused by viruses.
- #5 MMR (measles, mumps and rubella) vaccine – NHShttps://www.nhs.uk/vaccinations/mmr-vaccine/
The MMR vaccine gives long-term protection against measles, mumps and rubella. […] 2 doses of the MMR vaccine gives you long-term protection. […] The MMR vaccine is recommended for all babies and young children, but older children and adults can have it if they were not vaccinated when they were younger. […] The MMR vaccine can be given at any age. […] If you were born before 1970 and have not had measles, mumps or rubella (german measles) or their vaccines, you can ask your GP surgery for the MMR vaccine. […] Most people who need the MMR vaccine can have it. […] The MMR vaccine is not given if: you’re pregnant, you have a weakened immune system, either because of a health condition or because you are taking medicines that suppress the immune system, you’ve had a serious allergic reaction (anaphylaxis) to any ingredients in the vaccine, including gelatine or neomycin.
- #6 Measles Vaccination | Measles (Rubeola) | CDChttps://www.cdc.gov/measles/vaccines/index.html
Two doses of the MMR vaccine are recommended by doctors as the best way to protect against measles, mumps, and rubella. […] The best way to protect against measles is to get the measles, mumps, and rubella (MMR) vaccine. […] Most people who are vaccinated with MMR MMRV will be protected for life. […] There are two vaccines that protect against measles, mumps, and rubella. […] Both MMR and MMRV vaccines may be given at the same time as other vaccines. […] Children need 2 doses of MMR vaccines: 1215 months old 1st dose 46 years old 2nd dose. […] Anyone traveling internationally should be fully vaccinated before traveling. […] If you don’t have immunity against these diseases and become exposed to them, talk with your doctor about getting MMR vaccine. […] The MMR vaccine protects your child from measles, mumps, and rubella, potentially serious diseases caused by viruses.
- #7 M-M-R II, Priorix (measles mumps and rubella vaccine, live) dosing, indications, interactions, adverse effects, and morehttps://reference.medscape.com/drug/mmrii-priorix-measles-mumps-and-rubella-vaccine-live-343159
Adults born before 1957 are considered immune to measles and mumps; all adults born in 1957 or later should have documentation of 1 or more doses of MMR vaccine unless contraindicated, or laboratory evidence of immunity to each of the 3 diseases. […] Pregnant women who do not have evidence of immunity should receive MMR vaccine upon completion or termination of pregnancy and before discharge from the health-care facility. […] Vaccination should be deferred in individuals with a family history of congenital or hereditary immunodeficiency until the individuals immune status has been evaluated and the individual has been found to be immunocompetent. […] There is a risk of fever and associated febrile seizure in first 2 weeks following immunization with M-M-RII vaccine; for children who have experienced a previous febrile seizure (from any cause) and those with a family history of febrile seizures there is a small increase in risk of febrile seizure following receipt of M-M-RII vaccine. […] Live, attenuated viruses stimulate active immunity to disease caused by measles, rubella, and mumps viruses.
- #8 Adult MMR Vaccine: Advantages, Side Effects, Guidelineshttps://www.webmd.com/vaccines/adult-mmr-vaccine-guidelines
The MMR vaccine protects you from measles, mumps, and rubella. All three of these diseases spread easily, so it’s important to get this vaccine. […] The MMR vaccine protects against measles, mumps, and rubella. […] The CDC recommends that you get the MMR vaccine unless you have: […] The three diseases covered by the MMR vaccine are highly contagious. […] The CDC says most adults born in 1957 or later should get at least one dose of the MMR vaccine. […] The CDC says adults at greater risk of measles or mumps should get two doses of MMR vaccine, the second one four weeks after the first. […] If you were born before 1957 but can’t show proof that you’re immune to or had measles, mumps, and rubella, it’s best to get the MMR vaccine. […] Adults don’t need the MMR vaccine if: […] Adults who shouldn’t get the MMR vaccine include people in these groups: […] The safest and most effective ingredients in the MMR vaccine used today include „attenuated” forms of each virus. […] For most adults, the benefits of the MMR vaccine outweigh the risks.
- #9 MMR Vaccine: Care Instructions | Kaiser Permanentehttps://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.mmr-vaccine-care-instructions.zc1879
An MMR vaccine protects against measles, mumps, and rubella. These diseases used to be common in children before the vaccine. Children get two doses of the MMR vaccine. They get the first dose when they are 12 to 15 months old and the second dose at 4 to 6 years old. Be sure to follow the vaccine schedule your doctor gives you. These shots will prevent measles, mumps, and rubella for life. […] Sometimes doctors recommend the MMR vaccine for a child younger than 1 year if there is a measles outbreak. The vaccine also may be given to babies who will travel outside the United States. An MMR vaccine given before age 1 must be repeated when the child is older than 1. […] Some parents worry that the MMR vaccine causes autism spectrum disorder (ASD) in children. But many studies have been done, and no link has been found between the MMR vaccine and ASD.
- #10 MMR Vaccine – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK554450/
The ACIP recommends that vaccine doses in a series should be obtained from the same manufacturer; however, vaccination should not be delayed if the vaccine from the same manufacturer is unavailable. […] The first dose should be administered to individuals aged 12 to 15 months, and the second should be administered between the ages of 4 and 6 years. […] The recommendation is to administer the first and/or second dose of MMR vaccine in advance to children who live in or travel to areas with an outbreak of measles. […] In children with epilepsy, the recommendation is to administer antipyretic drugs for 6 to 12 days after administration of MMR, as fever that may occur as an adverse reaction may trigger seizures. […] The MMR vaccine remains vital for preventing measles, mumps, and rubella, but smoking may impair optimal antibody response.
- #11 Measles Vaccination | Measles (Rubeola) | CDChttps://www.cdc.gov/measles/vaccines/index.html
MMR vaccine protects your child from getting an uncomfortable rash and high fever from measles. […] MMR vaccine protects your child from getting a fever and swollen glands under the ears or jaw from mumps. […] MMR vaccine prevents your child from getting a rash and fever from rubella. […] MMR vaccination is important for children as well as adults who do not have evidence of immunity. […] MMR vaccine is very safe and is effective at preventing measles, mumps, and rubella. […] One dose of MMR vaccine is 93% effective against measles, 72% effective against mumps, and 97% effective against rubella. […] Two doses of MMR vaccine are 97% effective against measles and 86% effective against mumps. […] While MMR provides effective protection against mumps for most people, immunity against mumps may decrease over time for some people.
- #12 MMR Vaccine (Measles, Mumps & Rubella Vaccination)https://my.clevelandclinic.org/health/procedures/mmr-vaccine
The MMR vaccine reduces your risk of getting measles, mumps and rubella. These are all highly contagious viral infections that can cause serious, life-threatening health conditions. […] The MMR vaccine can provide strong protection against measles, mumps and rubella and the complications caused by these diseases. […] One dose of the MMR vaccine is 93% effective in preventing measles. […] Two doses of the MMR vaccine are 97% effective in preventing measles. […] The MMR vaccine has made measles, mumps and rubella much less common in the U.S. Most people who receive the MMR vaccine are protected for life against measles and rubella.
- #13 Measles Vaccination | Measles (Rubeola) | CDChttps://www.cdc.gov/measles/vaccines/index.html
MMR vaccine protects your child from getting an uncomfortable rash and high fever from measles. […] MMR vaccine protects your child from getting a fever and swollen glands under the ears or jaw from mumps. […] MMR vaccine prevents your child from getting a rash and fever from rubella. […] MMR vaccination is important for children as well as adults who do not have evidence of immunity. […] MMR vaccine is very safe and is effective at preventing measles, mumps, and rubella. […] One dose of MMR vaccine is 93% effective against measles, 72% effective against mumps, and 97% effective against rubella. […] Two doses of MMR vaccine are 97% effective against measles and 86% effective against mumps. […] While MMR provides effective protection against mumps for most people, immunity against mumps may decrease over time for some people.
- #14 MMR (measles, mumps and rubella) vaccinehttps://www2.hse.ie/conditions/mmr-vaccine/
After 2 doses: around 99% of people are protected against measles and rubella, around 88% of people are protected against mumps. […] The MMR vaccine is very safe. […] Most side effects are mild and do not last long. […] It’s rare for anyone to have a serious allergic reaction to a vaccine. […] The MMR vaccine is safe for anyone with a severe egg allergy. […] There’s no evidence of any link between the MMR vaccine and autism.
- #15 Measles Vaccination | Measles (Rubeola) | CDChttps://www.cdc.gov/measles/vaccines/index.html
Two doses of the MMR vaccine are recommended by doctors as the best way to protect against measles, mumps, and rubella. […] The best way to protect against measles is to get the measles, mumps, and rubella (MMR) vaccine. […] Most people who are vaccinated with MMR MMRV will be protected for life. […] There are two vaccines that protect against measles, mumps, and rubella. […] Both MMR and MMRV vaccines may be given at the same time as other vaccines. […] Children need 2 doses of MMR vaccines: 1215 months old 1st dose 46 years old 2nd dose. […] Anyone traveling internationally should be fully vaccinated before traveling. […] If you don’t have immunity against these diseases and become exposed to them, talk with your doctor about getting MMR vaccine. […] The MMR vaccine protects your child from measles, mumps, and rubella, potentially serious diseases caused by viruses.
- #16 MMR (measles, mumps and rubella) vaccine – NHShttps://www.nhs.uk/vaccinations/mmr-vaccine/
The MMR vaccine gives long-term protection against measles, mumps and rubella. […] 2 doses of the MMR vaccine gives you long-term protection. […] The MMR vaccine is recommended for all babies and young children, but older children and adults can have it if they were not vaccinated when they were younger. […] The MMR vaccine can be given at any age. […] If you were born before 1970 and have not had measles, mumps or rubella (german measles) or their vaccines, you can ask your GP surgery for the MMR vaccine. […] Most people who need the MMR vaccine can have it. […] The MMR vaccine is not given if: you’re pregnant, you have a weakened immune system, either because of a health condition or because you are taking medicines that suppress the immune system, you’ve had a serious allergic reaction (anaphylaxis) to any ingredients in the vaccine, including gelatine or neomycin.
- #17 Ask The Experts About Vaccines: MMR (Measles, Mumps, and Rubella) | Immunize.orghttps://www.immunize.org/ask-experts/topic/mmr/
MMR vaccine is recommended for all healthcare personnel born during or after 1957. […] During an outbreak of measles or mumps, healthcare facilities should recommend 2 doses of MMR separated by at least 4 weeks for unvaccinated healthcare personnel regardless of birth year who lack laboratory evidence of measles or mumps immunity. […] MMR vaccination during pregnancy is not a reason to terminate the pregnancy. […] Breastfeeding does not interfere with the response to MMR vaccine. […] People with medical conditions that contraindicate measles immunization depend on high MMR vaccination coverage among those around them. […] MMR and varicella vaccines should be given to the healthy household contacts of immunosuppressed children. […] ACIP recommends that all HCP born during or after 1957 have adequate presumptive evidence of immunity to measles, mumps, and rubella.
- #18 Measles Vaccination | Measles (Rubeola) | CDChttps://www.cdc.gov/measles/vaccines/index.html
Two doses of the MMR vaccine are recommended by doctors as the best way to protect against measles, mumps, and rubella. […] The best way to protect against measles is to get the measles, mumps, and rubella (MMR) vaccine. […] Most people who are vaccinated with MMR MMRV will be protected for life. […] There are two vaccines that protect against measles, mumps, and rubella. […] Both MMR and MMRV vaccines may be given at the same time as other vaccines. […] Children need 2 doses of MMR vaccines: 1215 months old 1st dose 46 years old 2nd dose. […] Anyone traveling internationally should be fully vaccinated before traveling. […] If you don’t have immunity against these diseases and become exposed to them, talk with your doctor about getting MMR vaccine. […] The MMR vaccine protects your child from measles, mumps, and rubella, potentially serious diseases caused by viruses.
- #19 MMR (measles, mumps and rubella) vaccinehttps://www2.hse.ie/conditions/mmr-vaccine/
The MMR vaccine is a safe and effective combined vaccine. […] 2 doses of the MMR vaccine provide the best protection. […] Anyone who has not had 2 doses of the MMR vaccine can get the vaccine. […] It is important to get the vaccine if you: are under 25, live in shared or crowded accommodation, live with vulnerable people who do not have immunity and cannot get the vaccine, were born outside of Ireland and do not have immunity to measles, are a healthcare worker with direct patient contact, plan to get pregnant, plan to travel abroad to an area where there is a measles outbreak or regular cases of measles. […] The MMR vaccine is given as 2 doses of a single injection into the muscle of the upper arm or thigh. […] You need 2 doses of the vaccine to have full protection. […] The MMR vaccine is very effective.
- #20 Rubella (German Measles): Symptoms, Treatment & Preventionhttps://my.clevelandclinic.org/health/diseases/17798-rubella
How is rubella treated? […] The best way to prevent rubella is vaccination with the MMR (or MMRV) vaccine. […] Rubella vaccination can involve either the MMR or the MMRV vaccine. […] The MMR vaccine protects against measles, mumps and rubella. […] Most children and adults over the age of 12 can get vaccinated against rubella. […] If you plan to start a family, you should get vaccinated or tested for rubella antibodies at least one month before trying to get pregnant. […] The ways to treat congenital rubella syndrome depend on its severity. Some conditions are treatable with medication or surgery. Other damage is permanent, and its only possible to manage the condition to improve quality of life.
- #21 Ask The Experts About Vaccines: MMR (Measles, Mumps, and Rubella) | Immunize.orghttps://www.immunize.org/ask-experts/topic/mmr/
MMR vaccine is recommended routinely for all children at age 12 through 15 months, with a second dose at age 4 through 6 years. […] Adults with no evidence of immunity should get 1 dose of MMR vaccine. […] High-risk people include school-age children, healthcare personnel, international travelers, and students attending post-high school educational institutions. […] MMR vaccine given within 72 hours of initial measles exposure can reduce the risk of getting sick or reduce the severity of symptoms. […] Measles vaccine, given as MMR, may be effective if given within the first 3 days (72 hours) after exposure to measles. […] MMR can be given to children as young as 6 months of age who are at high risk of exposure such as during international travel or a community outbreak. […] The second dose of MMR may be given as early as 4 weeks after the first dose, and be counted as a valid dose, if both doses were given after the first birthday.
- #22 M-M-R II, Priorix (measles mumps and rubella vaccine, live) dosing, indications, interactions, adverse effects, and morehttps://reference.medscape.com/drug/mmrii-priorix-measles-mumps-and-rubella-vaccine-live-343159
Adults born before 1957 are considered immune to measles and mumps; all adults born in 1957 or later should have documentation of 1 or more doses of MMR vaccine unless contraindicated, or laboratory evidence of immunity to each of the 3 diseases. […] Pregnant women who do not have evidence of immunity should receive MMR vaccine upon completion or termination of pregnancy and before discharge from the health-care facility. […] Vaccination should be deferred in individuals with a family history of congenital or hereditary immunodeficiency until the individuals immune status has been evaluated and the individual has been found to be immunocompetent. […] There is a risk of fever and associated febrile seizure in first 2 weeks following immunization with M-M-RII vaccine; for children who have experienced a previous febrile seizure (from any cause) and those with a family history of febrile seizures there is a small increase in risk of febrile seizure following receipt of M-M-RII vaccine. […] Live, attenuated viruses stimulate active immunity to disease caused by measles, rubella, and mumps viruses.
- #23 Measles, Mumps, and Rubella (MMR) Vaccine – Infectious Diseases – Merck Manual Professional Editionhttps://www.merckmanuals.com/professional/infectious-diseases/immunization/measles-mumps-and-rubella-mmr-vaccine
People who were vaccinated with inactivated (killed) measles vaccine or measles vaccine of unknown type during 1963 to 1967 should be revaccinated with 2 doses of MMR vaccine. […] People who were vaccinated before 1979 with killed mumps vaccine or mumps vaccine of unknown type and who are at high risk of mumps exposure should be offered revaccination with 2 doses of MMR vaccine. […] Contraindications for the MMR vaccine include a severe allergic reaction (eg, anaphylaxis) after a previous dose or to a vaccine component, including neomycin. […] Women who have been vaccinated should avoid becoming pregnant for 28 days afterward. The vaccine virus may be capable of infecting a fetus during early pregnancy. […] The MMR vaccine dose is 0.5 mL subcutaneous. The MMR vaccine is routinely given to children in 2 doses: one at age 12 to 15 months and one at age 4 to 6 years.
- #24 Measles Vaccination Recommendations – MN Dept. of Healthhttps://www.health.state.mn.us/diseases/measles/hcp/vaxrecs.html
Vaccination is the best way to prevent measles. Measles vaccine is available combined with mumps and rubella vaccines as MMR, or MMR combined with varicella vaccine as MMRV. The MMR vaccine is a live-attenuated (weakened) vaccine that produces a mild, non-infectious response. […] MMR vaccine provides long-lasting protection against measles. […] Patients who are severely immunocompromised for any reason should not be given MMR vaccine. However, HIV-infected individuals may receive MMR vaccination if they are not severely immunosuppressed. […] Women known to be pregnant should not receive measles vaccine. Pregnancy should be avoided for 4 weeks following MMR vaccine. […] MMR vaccine is about 93 percent effective at preventing measles after one dose and about 97 percent effective after two doses.
- #25 MMR (measles, mumps and rubella) vaccine – NHShttps://www.nhs.uk/vaccinations/mmr-vaccine/
You can have the MMR vaccine if you’re unwell but do not have a high temperature. […] The MMR vaccine is given as an injection into the upper arm or thigh. It’s often given at the same time as other routine vaccinations. […] You’ll need 2 doses for full protection. […] Like all medicines, the MMR vaccine can cause side effects, but not everyone will get them. […] Common side effects are usually mild and only last 2 to 3 days, they include: a raised, blotchy rash (similar to a measles rash), feeling unwell and a high temperature around 7 to 11 days after the vaccination. […] Protection starts within 2 weeks of having the MMR vaccine. […] After 2 doses: around 99% of people will be protected against measles and rubella, around 88% of people will be protected against mumps.
- #26 M-M-R®II (Measles, Mumps, and Rubella Virus Vaccine Live) | Official Sitehttps://www.merckvaccines.com/mmr/
M-M-RII is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age or older. […] The first dose of M-M-RII is administered at 12 to 15 months of age and the second dose of M-M-RII is administered at 4 to 6 years of age. […] M-M-RII is contraindicated in certain individuals, including those with: a history of hypersensitivity to any component of the vaccine, including gelatin; a history of anaphylactic reaction to neomycin; individuals who are immunodeficient or immunosuppressed due to disease or medical therapy; an active febrile illness; active untreated tuberculosis; or those who are pregnant or are planning to become pregnant within the next month. […] Vaccination should be deferred in individuals with a family history of congenital or hereditary immunodeficiency until the individuals immune status has been evaluated and the individual has been found to be immunocompetent. […] M-M-RII vaccine can be administered concurrently with other live viral vaccines. If not given concurrently, M-M-RII vaccine should be given one month before or one month after administration of other live viral vaccines to avoid potential for immune interference.
- #27 M-M-R®II (Measles, Mumps, and Rubella Virus Vaccine Live) | Official Sitehttps://www.merckvaccines.com/mmr/
M-M-RII is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age or older. […] The first dose of M-M-RII is administered at 12 to 15 months of age and the second dose of M-M-RII is administered at 4 to 6 years of age. […] M-M-RII is contraindicated in certain individuals, including those with: a history of hypersensitivity to any component of the vaccine, including gelatin; a history of anaphylactic reaction to neomycin; individuals who are immunodeficient or immunosuppressed due to disease or medical therapy; an active febrile illness; active untreated tuberculosis; or those who are pregnant or are planning to become pregnant within the next month. […] Vaccination should be deferred in individuals with a family history of congenital or hereditary immunodeficiency until the individuals immune status has been evaluated and the individual has been found to be immunocompetent. […] M-M-RII vaccine can be administered concurrently with other live viral vaccines. If not given concurrently, M-M-RII vaccine should be given one month before or one month after administration of other live viral vaccines to avoid potential for immune interference.
- #28 MMR (measles, mumps and rubella) vaccine – NHShttps://www.nhs.uk/vaccinations/mmr-vaccine/
You can have the MMR vaccine if you’re unwell but do not have a high temperature. […] The MMR vaccine is given as an injection into the upper arm or thigh. It’s often given at the same time as other routine vaccinations. […] You’ll need 2 doses for full protection. […] Like all medicines, the MMR vaccine can cause side effects, but not everyone will get them. […] Common side effects are usually mild and only last 2 to 3 days, they include: a raised, blotchy rash (similar to a measles rash), feeling unwell and a high temperature around 7 to 11 days after the vaccination. […] Protection starts within 2 weeks of having the MMR vaccine. […] After 2 doses: around 99% of people will be protected against measles and rubella, around 88% of people will be protected against mumps.
- #29 MMR Vaccine – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK554450/
The most common adverse events have been reported (10%) in clinical trials in the drug product label of Priorix vaccine by age group. […] Adverse events tend to occur with the first dose of the medication; one to 3 weeks following vaccination, 5% of immunized children experience malaise and fever, which can present with or without a rash that lasts up to 3 days. […] The trace amount of egg or chicken protein in the MMR and MMRV vaccines is insufficient to cause an allergic reaction in those who are egg-allergic. […] The administration of an additional dose of a vaccine may be necessary in cases where there is uncertainty about a person’s vaccination history or due to programmatic errors, such as vaccination mistakes or errors in the vaccination process.
- #30 MMR (measles, mumps and rubella) vaccinehttps://www2.hse.ie/conditions/mmr-vaccine/
After 2 doses: around 99% of people are protected against measles and rubella, around 88% of people are protected against mumps. […] The MMR vaccine is very safe. […] Most side effects are mild and do not last long. […] It’s rare for anyone to have a serious allergic reaction to a vaccine. […] The MMR vaccine is safe for anyone with a severe egg allergy. […] There’s no evidence of any link between the MMR vaccine and autism.
- #31 MMR vaccine – Wikipediahttps://en.wikipedia.org/wiki/MMR_vaccine
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles), abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection. […] The MMR vaccine is widely used around the world. As of 2012, 575 million doses had been administered since the vaccine’s introduction worldwide. Measles resulted in 2.6 million deaths per year before immunization became common. This has decreased to 122,000 deaths per year as of 2012, mostly in low-income countries. Through vaccination, as of 2018, rates of measles in North and South America are very low. Rates of disease have been seen to increase in populations that go unvaccinated. Between 2000 and 2018, vaccination decreased measles deaths by 73%.
- #32 MMR vaccine – Wikipediahttps://en.wikipedia.org/wiki/MMR_vaccine
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles), abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection. […] The MMR vaccine is widely used around the world. As of 2012, 575 million doses had been administered since the vaccine’s introduction worldwide. Measles resulted in 2.6 million deaths per year before immunization became common. This has decreased to 122,000 deaths per year as of 2012, mostly in low-income countries. Through vaccination, as of 2018, rates of measles in North and South America are very low. Rates of disease have been seen to increase in populations that go unvaccinated. Between 2000 and 2018, vaccination decreased measles deaths by 73%.
- #33 Measles Vaccination | Measles (Rubeola) | CDChttps://www.cdc.gov/measles/vaccines/index.html
MMR vaccine protects your child from getting an uncomfortable rash and high fever from measles. […] MMR vaccine protects your child from getting a fever and swollen glands under the ears or jaw from mumps. […] MMR vaccine prevents your child from getting a rash and fever from rubella. […] MMR vaccination is important for children as well as adults who do not have evidence of immunity. […] MMR vaccine is very safe and is effective at preventing measles, mumps, and rubella. […] One dose of MMR vaccine is 93% effective against measles, 72% effective against mumps, and 97% effective against rubella. […] Two doses of MMR vaccine are 97% effective against measles and 86% effective against mumps. […] While MMR provides effective protection against mumps for most people, immunity against mumps may decrease over time for some people.
- #34 Measles Vaccination | Measles (Rubeola) | CDChttps://www.cdc.gov/measles/vaccines/index.html
MMR vaccine protects your child from getting an uncomfortable rash and high fever from measles. […] MMR vaccine protects your child from getting a fever and swollen glands under the ears or jaw from mumps. […] MMR vaccine prevents your child from getting a rash and fever from rubella. […] MMR vaccination is important for children as well as adults who do not have evidence of immunity. […] MMR vaccine is very safe and is effective at preventing measles, mumps, and rubella. […] One dose of MMR vaccine is 93% effective against measles, 72% effective against mumps, and 97% effective against rubella. […] Two doses of MMR vaccine are 97% effective against measles and 86% effective against mumps. […] While MMR provides effective protection against mumps for most people, immunity against mumps may decrease over time for some people.
- #35 Measles, mumps, and rubella immunization in adults – UpToDatehttps://www.uptodate.com/contents/measles-mumps-and-rubella-immunization-in-adults
The combination measles, mumps, and rubella (MMR) vaccine includes live virus vaccines against measles, mumps, and rubella; it is an important tool for preventing serious illness due to these infections. […] Issues related to the use of combination MMR vaccine in adults will be discussed here; use of MMR immunization in infants, children, and adolescents is discussed separately. […] The measles virus causes an acute infection characterized by fever, cough, coryza (rhinitis), conjunctivitis, rash, and enanthem that may be followed by severe complications including encephalitis. […] The mumps virus causes an acute infection characterized by parotid swelling. Mumps infection usually is self-limited but may be associated with complications including orchitis and oophoritis, aseptic meningitis, and encephalitis.
- #36 Measles Vaccination | Measles (Rubeola) | CDChttps://www.cdc.gov/measles/vaccines/index.html
MMR vaccine protects your child from getting an uncomfortable rash and high fever from measles. […] MMR vaccine protects your child from getting a fever and swollen glands under the ears or jaw from mumps. […] MMR vaccine prevents your child from getting a rash and fever from rubella. […] MMR vaccination is important for children as well as adults who do not have evidence of immunity. […] MMR vaccine is very safe and is effective at preventing measles, mumps, and rubella. […] One dose of MMR vaccine is 93% effective against measles, 72% effective against mumps, and 97% effective against rubella. […] Two doses of MMR vaccine are 97% effective against measles and 86% effective against mumps. […] While MMR provides effective protection against mumps for most people, immunity against mumps may decrease over time for some people.
- #37 MMR Vaccine – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK554450/
Measles, mumps, and rubella (MMR) vaccine effectively prevents measles by stimulating the immune system to produce antibodies against the live-attenuated virus. […] Routine immunization is recommended for children, adolescents, and adults born after 1957 without prior immunity, with specific indications for healthcare professionals, military personnel, and international travelers. Vaccination significantly reduces the incidence of measles and its complications, contributing to herd immunity. […] The MMR vaccine is a live attenuated combination vaccine formulated with live attenuated viruses, making it a harmless, less-virulent version of the infectious agents it targets. This vaccine prevents infectious diseases such as measles, mumps, and rubella by strengthening the immune system. […] Vaccinating women before or during reproductive years is also important, as rubella can cause congenital malformations in the fetus.
- #38 Ask The Experts About Vaccines: MMR (Measles, Mumps, and Rubella) | Immunize.orghttps://www.immunize.org/ask-experts/topic/mmr/
MMR vaccine is recommended routinely for all children at age 12 through 15 months, with a second dose at age 4 through 6 years. […] Adults with no evidence of immunity should get 1 dose of MMR vaccine. […] High-risk people include school-age children, healthcare personnel, international travelers, and students attending post-high school educational institutions. […] MMR vaccine given within 72 hours of initial measles exposure can reduce the risk of getting sick or reduce the severity of symptoms. […] Measles vaccine, given as MMR, may be effective if given within the first 3 days (72 hours) after exposure to measles. […] MMR can be given to children as young as 6 months of age who are at high risk of exposure such as during international travel or a community outbreak. […] The second dose of MMR may be given as early as 4 weeks after the first dose, and be counted as a valid dose, if both doses were given after the first birthday.
- #39 Measles vaccines: Canadian immunization guide – Canada.cahttps://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-12-measles-vaccine.html
Routine childhood immunization: 2 doses of any measles-containing (MMR or MMRV) vaccine. […] The goal of measles post-exposure prophylaxis (PEP) is to prevent severe disease, including hospitalization, as well as to prevent mortality. […] Administration of measles PEP as soon as possible following measles exposure is recommended and should be offered to individuals not expected to be immune to measles. […] Prophylactic use of MMR vaccine has been shown to be effective if provided within 72 hours of exposure while the prophylactic use of human immunoglobulin (Ig) has been shown to be effective in modifying or preventing disease if administered within 6 days after exposure to measles. […] Measles-containing vaccine is recommended for routine immunization of children and for immunization of children and adolescents who missed measles immunization on the routine schedule. […] Individuals who are immunocompromised, either due to underlying conditions or immunosuppressive agents, are more susceptible to infections including measles. […] The safety and effectiveness of the measles vaccine is determined by the type of immunodeficiency and degree of immunosuppression.
- #40 Measles Vaccination | Measles (Rubeola) | CDChttps://www.cdc.gov/measles/vaccines/index.html
Most people don’t have any side effects from the vaccine. […] The side effects that do occur are usually mild, and may include soreness, redness, or swelling where the vaccine was given. […] The MMR vaccine is safe. There’s no harm in getting another dose if you may already be immune to measles, mumps, or rubella.
- #41 MMR (measles, mumps and rubella) vaccinehttps://www2.hse.ie/conditions/mmr-vaccine/
After 2 doses: around 99% of people are protected against measles and rubella, around 88% of people are protected against mumps. […] The MMR vaccine is very safe. […] Most side effects are mild and do not last long. […] It’s rare for anyone to have a serious allergic reaction to a vaccine. […] The MMR vaccine is safe for anyone with a severe egg allergy. […] There’s no evidence of any link between the MMR vaccine and autism.
- #42 Measles Vaccination | Measles (Rubeola) | CDChttps://www.cdc.gov/measles/vaccines/index.html
Most people don’t have any side effects from the vaccine. […] The side effects that do occur are usually mild, and may include soreness, redness, or swelling where the vaccine was given. […] The MMR vaccine is safe. There’s no harm in getting another dose if you may already be immune to measles, mumps, or rubella.
- #43 Measles, mumps, rubella, varicella (chickenpox) â immunisation | Better Health Channelhttps://www.betterhealth.vic.gov.au/health/healthyliving/measles-mumps-rubella-varicella-chickenpox-immunisation
Immunisation against measles, mumps and rubella can be provided with the MMR combination vaccine. […] Immunisation with MMRV vaccine at 18 months gives very young children early protection against measles, mumps, rubella and chickenpox. […] The combined MMR and MMRV vaccines are effective and safe, but all medications can have unwanted side effects. […] Common side effects following immunisation are usually mild and temporary (occurring in the first few days after vaccination). Specific treatment is not usually required. […] Side effects from MMR and MMRV vaccines that can occur 7 to 10 days after vaccination include: fever (can be more than 39.4 C), lasting 2 to 3 days, faint red rash (not infectious), head cold, runny nose, cough or puffy eyes, drowsiness or tiredness, swelling of salivary glands, localised pain, redness and swelling at the injection site. […] If any other reactions are severe and persistent, or if you are worried, contact your doctor for further information.
- #44 Measles, mumps, rubella, varicella (chickenpox) â immunisation | Better Health Channelhttps://www.betterhealth.vic.gov.au/health/healthyliving/measles-mumps-rubella-varicella-chickenpox-immunisation
Immunisation against measles, mumps and rubella can be provided with the MMR combination vaccine. […] Immunisation with MMRV vaccine at 18 months gives very young children early protection against measles, mumps, rubella and chickenpox. […] The combined MMR and MMRV vaccines are effective and safe, but all medications can have unwanted side effects. […] Common side effects following immunisation are usually mild and temporary (occurring in the first few days after vaccination). Specific treatment is not usually required. […] Side effects from MMR and MMRV vaccines that can occur 7 to 10 days after vaccination include: fever (can be more than 39.4 C), lasting 2 to 3 days, faint red rash (not infectious), head cold, runny nose, cough or puffy eyes, drowsiness or tiredness, swelling of salivary glands, localised pain, redness and swelling at the injection site. […] If any other reactions are severe and persistent, or if you are worried, contact your doctor for further information.
- #45 MMR (measles, mumps and rubella) vaccine – NHShttps://www.nhs.uk/vaccinations/mmr-vaccine/
You can have the MMR vaccine if you’re unwell but do not have a high temperature. […] The MMR vaccine is given as an injection into the upper arm or thigh. It’s often given at the same time as other routine vaccinations. […] You’ll need 2 doses for full protection. […] Like all medicines, the MMR vaccine can cause side effects, but not everyone will get them. […] Common side effects are usually mild and only last 2 to 3 days, they include: a raised, blotchy rash (similar to a measles rash), feeling unwell and a high temperature around 7 to 11 days after the vaccination. […] Protection starts within 2 weeks of having the MMR vaccine. […] After 2 doses: around 99% of people will be protected against measles and rubella, around 88% of people will be protected against mumps.
- #46 Measles, mumps and rubella (MMR) vaccinehttps://info.health.nz/immunisations/vaccines-aotearoa/measles-mumps-and-rubella-mmr-vaccine
Adults need to be up to date with MMR vaccinations to protect themselves and their community. […] The MMR vaccine is free for everyone aged 18 years old and under (it does not matter what their visa or citizenship status is) and those eligible for free healthcare in New Zealand. […] If you are pregnant, you cannot have the MMR vaccine when you are pregnant. […] The vaccine we use in New Zealand is Priorix. This vaccine which protects against measles, mumps, and rubella. 2 doses, at least a month apart, are needed for best protection. […] Like most medicines, vaccines can sometimes cause reactions. These are usually mild, and not everyone will get them. […] Other common reactions of the MMR vaccine include mild rash between 6 and 12 days after immunisation, high fever over 39C between 6 and 12 days after immunisation, swollen glands in the cheeks, neck, or under the jaw, temporary joint pain 2 to 4 weeks after immunisation.
- #47 Measles, mumps, rubella, varicella (chickenpox) â immunisation | Better Health Channelhttps://www.betterhealth.vic.gov.au/health/healthyliving/measles-mumps-rubella-varicella-chickenpox-immunisation
Immunisation against measles, mumps and rubella can be provided with the MMR combination vaccine. […] Immunisation with MMRV vaccine at 18 months gives very young children early protection against measles, mumps, rubella and chickenpox. […] The combined MMR and MMRV vaccines are effective and safe, but all medications can have unwanted side effects. […] Common side effects following immunisation are usually mild and temporary (occurring in the first few days after vaccination). Specific treatment is not usually required. […] Side effects from MMR and MMRV vaccines that can occur 7 to 10 days after vaccination include: fever (can be more than 39.4 C), lasting 2 to 3 days, faint red rash (not infectious), head cold, runny nose, cough or puffy eyes, drowsiness or tiredness, swelling of salivary glands, localised pain, redness and swelling at the injection site. […] If any other reactions are severe and persistent, or if you are worried, contact your doctor for further information.
- #48 Schedule MMR Vaccine (Measles, Mumps & Rubella) | Walgreenshttps://www.walgreens.com/topic/pharmacy/scheduler/measles-mumps-rubella-mmr-vaccine_38.jsp
Mild-to-moderate side effects: Fever, rash and seizures, Swollen glands in the cheeks or neck, Temporary pain and stiffness in the joints, Temporary low blood platelet count. […] Severe side effects, although rare, may include serious allergic reactions. Symptoms include: Deafness, Permanent brain damage, Difficulty breathing, Wheezing, Hives, Pale skin, Fast heartbeat, Dizziness.
- #49 What you should know about measles and how the MMR vaccine can protect your familymenu iconsearch iconsubscribe iconsearch iconarrow up right iconhttps://health.ucdavis.edu/blog/cultivating-health/what-you-should-know-about-measles-and-how-the-mmr-vaccine-can-protect-your-family/2024/11
Measles, mumps, and rubella (MMR) vaccine provides the best protection from measles. The MMR vaccine provides lasting protection against all strains of measles. […] The MMR vaccine is given in two doses. The first dose is typically given to babies ages 12-15 months. The second dose is given between ages 4 and 6 years old. The MMR vaccine can safely be given with other vaccines. […] The MMR vaccine is considered safe and effective. It provides the most effective prevention against measles, mumps and rubella. Most children have very minor side effects and no long term effects after getting the vaccine. […] Studies have shown that there is a very small risk of febrile seizures in children under 7 years old. This happens in about 1 in 3,000-4,000 children, according to the CDC. The febrile seizures would happen 6-14 days after MMR vaccination.
- #50 M-M-R II, Priorix (measles mumps and rubella vaccine, live) dosing, indications, interactions, adverse effects, and morehttps://reference.medscape.com/drug/mmrii-priorix-measles-mumps-and-rubella-vaccine-live-343159
Adults born before 1957 are considered immune to measles and mumps; all adults born in 1957 or later should have documentation of 1 or more doses of MMR vaccine unless contraindicated, or laboratory evidence of immunity to each of the 3 diseases. […] Pregnant women who do not have evidence of immunity should receive MMR vaccine upon completion or termination of pregnancy and before discharge from the health-care facility. […] Vaccination should be deferred in individuals with a family history of congenital or hereditary immunodeficiency until the individuals immune status has been evaluated and the individual has been found to be immunocompetent. […] There is a risk of fever and associated febrile seizure in first 2 weeks following immunization with M-M-RII vaccine; for children who have experienced a previous febrile seizure (from any cause) and those with a family history of febrile seizures there is a small increase in risk of febrile seizure following receipt of M-M-RII vaccine. […] Live, attenuated viruses stimulate active immunity to disease caused by measles, rubella, and mumps viruses.
- #51 MMR vaccine – Wikipediahttps://en.wikipedia.org/wiki/MMR_vaccine
Adverse reactions, rarely serious, may occur from each component of the MMR vaccine. Ten percent of children develop fever, malaise, and a rash 5-21 days after the first vaccination; and 3% develop joint pain lasting 18 days on average. Anaphylaxis is an extremely rare but serious allergic reaction to the vaccine. One cause can be egg allergy. In 2014, the FDA approved two additional possible adverse events on the vaccination label: acute disseminated encephalomyelitis (ADEM), and transverse myelitis, with permission to also add „difficulty walking” to the package inserts. A 2012 IOM report found that the measles component of the MMR vaccine can cause measles inclusion body encephalitis in immunocompromised individuals. This report also rejected any connection between the MMR vaccine and autism.
- #52 MMR (measles, mumps, and rubella) vaccine – what you need to know: MedlinePlus Medical EncyclopediaLockhttps://medlineplus.gov/ency/article/007603.htm
MMR vaccine can prevent measles, mumps, and rubella. […] Most people who are vaccinated with MMR will be protected for life. Vaccines and high rates of vaccination have made these diseases much less common in the United States. […] Children need 2 doses of MMR vaccine, usually: First dose at age 12 through 15 months; Second dose at age 4 through 6 years. […] A third dose of MMR might be recommended for certain people in mumps outbreak situations. […] MMR vaccine may be given at the same time as other vaccines. […] Talk with your health care provider. […] Risks of a vaccine reaction include sore arm from the injection or redness where the shot is given, fever, and a mild rash can happen after MMR vaccination. […] More serious reactions happen rarely. These can include seizures (often associated with fever) or temporary low platelet count that can cause unusual bleeding or bruising.
- #53 Immunisation for babies aged 12 or 13 months | nidirecthttps://www.nidirect.gov.uk/articles/immunisation-babies-aged-12-or-13-months
About two weeks after vaccination, when the rubella part of the vaccine starts to work, your child might get a rash of small bruise-like spots. This is a rare side effect. […] About three weeks after vaccination, when the mumps part of the vaccine starts to work, your child might get a mild form of mumps. This is a rare side effect and will heal without treatment. […] On rare occasions, 1 in 1000 children may have a fit due to a high temperature caused by the MMR vaccine. […] Anaphylaxis (serious allergic reactions) after MMR vaccine is extremely rare and only occurs in around one person for every 4 to 14 million doses given. […] In extremely rare occasions, around one child in over 500,000, the MMR vaccine may cause encephalitis (inflammation of the brain). […] Your child will get a booster dose of the MMR vaccine before they start school.
- #54 Immunisation for babies aged 12 or 13 months | nidirecthttps://www.nidirect.gov.uk/articles/immunisation-babies-aged-12-or-13-months
About two weeks after vaccination, when the rubella part of the vaccine starts to work, your child might get a rash of small bruise-like spots. This is a rare side effect. […] About three weeks after vaccination, when the mumps part of the vaccine starts to work, your child might get a mild form of mumps. This is a rare side effect and will heal without treatment. […] On rare occasions, 1 in 1000 children may have a fit due to a high temperature caused by the MMR vaccine. […] Anaphylaxis (serious allergic reactions) after MMR vaccine is extremely rare and only occurs in around one person for every 4 to 14 million doses given. […] In extremely rare occasions, around one child in over 500,000, the MMR vaccine may cause encephalitis (inflammation of the brain). […] Your child will get a booster dose of the MMR vaccine before they start school.
- #55 MMR vaccine – Wikipediahttps://en.wikipedia.org/wiki/MMR_vaccine
Side effects of immunization are generally mild and resolve without any specific treatment. These may include fever, as well as pain or redness at the injection site. Severe allergic reactions occur in about one in a million people. Because it contains live viruses, the MMR vaccine is not recommended during pregnancy but may be given during breastfeeding. The vaccine is safe to give at the same time as other vaccines. Being recently immunized does not increase the risk of passing measles, mumps, or rubella on to others: That is, even though the vaccine contains live viruses, they are not transmitted. There is no evidence of an association between MMR immunisation and autistic spectrum disorders. The MMR vaccine is a mixture of live weakened viruses of the three diseases. […] The combined MMR vaccine induces immunity less painfully than three separate injections at the same time, and sooner and more efficiently than three injections given on different dates. Public Health England reports that providing a single combined vaccine as of 1988, rather than giving the option to have them also done separately, increased uptake of the vaccine.
- #56 MMR (Measles, Mumps, Rubella) Vaccine: Safety, Side Effects, Costhttps://www.everydayhealth.com/infectious-diseases/mmr-vaccine-for-measles-mumps-and-rubella/
The MMR vaccine is a powerful tool to prevent three highly contagious viral diseases: measles, mumps, and rubella (German measles). […] The MMR vaccine protects against a trio of illnesses that can cause severe and in some cases life-threatening complications. […] Vaccination not only protects you, it also protects vulnerable people around you. […] The MMR vaccine is recommended for everyone who hasnât been vaccinated or had these diseases. […] The MMR vaccine is not advised during pregnancy. […] The MMR vaccine is not safe for people with a history of any condition that causes bleeding or bruising. […] The MMR vaccine cannot give you measles. […] The MMR vaccine protects against measles, mumps, and rubella, all of which can cause severe illness. […] The vaccine is recommended for nearly everyone, with a two-dose schedule for children and certain adults. […] Large-scale studies have proven that the MMR vaccine does not cause autism. Serious complications from vaccination are rare.
- #57 Mumps, Measles, and Rubella Vaccine for the Treatment of a Recalcitrant Subungual Wart | Actas Dermo-Sifiliográficashttps://www.actasdermo.org/en-mumps-measles-rubella-vaccine-for-articulo-S1578219017303347
Mumps, Measles, and Rubella Vaccine for the Treatment of a Recalcitrant Subungual Wart […] it was decided to start immunotherapy treatment with the trivalent mumps, measles, and rubella (MMR) vaccine by local injection. […] After 5 sessions, inflammatory changes were observed in the area, with the appearance of edema and erythema, and after the seventh session the wart disappeared completely. […] The treatment of common warts at certain sites, such as the subungual region, can be frustrating. […] Immunotherapy techniques include contact allergens, such as diphencyprone and dinitrochlorobenzene, and immunomodulators, which can be topical, such as imiquimod, or oral, such as cimetidine and zinc sulfate. […] Furthermore, the immunomodulatory effect may act not only locally, but also at a distance, as it is not uncommon to see the disappearance of warts at distant sites.
- #58 Mumps, Measles, and Rubella Vaccine for the Treatment of a Recalcitrant Subungual Wart | Actas Dermo-Sifiliográficashttps://www.actasdermo.org/en-mumps-measles-rubella-vaccine-for-articulo-S1578219017303347
When patients have not been immunized, an initial dose of subcutaneous vaccine is recommended. […] The complete response rate varies between 27% and 81%, with each patient requiring a mean of 3.6 cycles at 2-week intervals. […] The most common adverse effects include pseudoinfluenza symptoms and pain at the site of injection; no serious adverse effects have been observed. […] In conclusion, the availability, cost-effectiveness, and absence of serious adverse effects of intralesional immunotherapy with the trivalent vaccine make it a useful option for the management of warts refractory to other treatments.
- #59https://www.ijord.com/index.php/ijord/article/view/787
The objective of the study was to evaluate and compare the efficacy, safety of cryotherapy versus intralesional measles, mumps, rubella (MMR) vaccine versus combination of cryotherapy and intralesional MMR vaccine in Indian patients with cutaneous wart. […] Group B received intralesional injection 0.1 to 0.3 ml of MMR vaccine alone and Group C received combination of group A and group B therapy. […] Immunotherapy with MMR is superior treatment than cryotherapy for cutaneous warts with minimum side effects but the combination of cryotherapy with intralesional MMR has shown to have complementary effect in treatment response. […] Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
- #60 Intralesional injection of tuberculin purified protein derivative (PPD) versus measles, mumps, and rubella (MMR) vaccine in treatment of molluscum contagiosum: a comparative study | Scientific Reportshttps://www.nature.com/articles/s41598-023-49182-2
Molluscum contagiosum (MC) is a skin and mucous membrane infection caused by the molluscum virus (MCV). To evaluate safety and efficacy of intralesional injection of tuberculin purified protein derivative (PPD) antigen injection versus MMR (mumps, measles, rubella) antigen for the treatment of molluscum contagiosum (MC). […] We established a good safety and efficacy profile for tuberculin PPD and MMR antigens in treatment of molluscum contagiosum. […] The advisory committee on immunization practices in Egypt recommends 2 compulsory doses of MMR vaccine for all children. […] To our knowledge no studies compared MMR and PPD for treating MC. Therefore we aimed to further evaluate the efficacy, safety and tolerability of both antigens compared to each other and to a control group in clearing MC lesions.
- #61 Intralesional injection of tuberculin purified protein derivative (PPD) versus measles, mumps, and rubella (MMR) vaccine in treatment of molluscum contagiosum: a comparative study | Scientific Reportshttps://www.nature.com/articles/s41598-023-49182-2
The results of the present study revealed complete clearance of the injected lesions in 12 patients (80%), partial response in 3 patients (20%) of group (A). In group (B), complete clearance of the treated warts was observed in 11 patients (73.3%) and partial response in 4 (26.7%) of patients. […] Comparison between groups A and B to control group C demonstrated significant rates of wart clearance (p0.001). Notably, no significant difference between the MMR and PPD-treated groups was demonstrated (p=0.666). […] In conclusion we demonstrated the efficacy, safety, tolerability and cost effectiveness of both tuberculin PPD and MMR antigens in clearing resistant MC with minimal side effects.
- #62 Mumps, Measles, and Rubella Vaccine for the Treatment of a Recalcitrant Subungual Wart | Actas Dermo-Sifiliográficashttps://www.actasdermo.org/en-mumps-measles-rubella-vaccine-for-articulo-S1578219017303347
When patients have not been immunized, an initial dose of subcutaneous vaccine is recommended. […] The complete response rate varies between 27% and 81%, with each patient requiring a mean of 3.6 cycles at 2-week intervals. […] The most common adverse effects include pseudoinfluenza symptoms and pain at the site of injection; no serious adverse effects have been observed. […] In conclusion, the availability, cost-effectiveness, and absence of serious adverse effects of intralesional immunotherapy with the trivalent vaccine make it a useful option for the management of warts refractory to other treatments.
- #63 MMR Vaccine – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK554450/
The ACIP recommends that vaccine doses in a series should be obtained from the same manufacturer; however, vaccination should not be delayed if the vaccine from the same manufacturer is unavailable. […] The first dose should be administered to individuals aged 12 to 15 months, and the second should be administered between the ages of 4 and 6 years. […] The recommendation is to administer the first and/or second dose of MMR vaccine in advance to children who live in or travel to areas with an outbreak of measles. […] In children with epilepsy, the recommendation is to administer antipyretic drugs for 6 to 12 days after administration of MMR, as fever that may occur as an adverse reaction may trigger seizures. […] The MMR vaccine remains vital for preventing measles, mumps, and rubella, but smoking may impair optimal antibody response.
- #64 2025 Measles Outbreak Guidancehttps://www.nmhealth.org/about/erd/ideb/mog/
Two doses of MMR vaccine provide the best protection against measles. […] The best way to prevent getting sick is to be immunized against measles. Two doses of the MMR (measles, mumps, rubella) vaccine are highly effective at preventing measles. […] The following public health offices will offer daily walk-in MMR vaccinations with no appointments needed until further notice: […] Amador Clinic staff in collaboration with the Department of Health will be providing MMR vaccine for children and qualifying adults. […] Fridays, May 23 and 30 from 1-4 p.m., the Santa Fe Public Office will be accepting walk-in MMR vaccinations with no appointment necessary. […] In addition to MMR vaccines, COVID-19 and flu vaccines are also available. […] MMR vaccinations are available at the Deming (Luna County) Public Health Office. […] 8 a.m. noon every Tuesday at the Albuquerque Midtown Public Health Office. […] The NMDOH Helpline can help you find local pharmacies with vaccine in stock, coordinate with public health offices to get you vaccinated and answer medical questions.
- #65 Ask The Experts About Vaccines: MMR (Measles, Mumps, and Rubella) | Immunize.orghttps://www.immunize.org/ask-experts/topic/mmr/
MMR vaccine is recommended routinely for all children at age 12 through 15 months, with a second dose at age 4 through 6 years. […] Adults with no evidence of immunity should get 1 dose of MMR vaccine. […] High-risk people include school-age children, healthcare personnel, international travelers, and students attending post-high school educational institutions. […] MMR vaccine given within 72 hours of initial measles exposure can reduce the risk of getting sick or reduce the severity of symptoms. […] Measles vaccine, given as MMR, may be effective if given within the first 3 days (72 hours) after exposure to measles. […] MMR can be given to children as young as 6 months of age who are at high risk of exposure such as during international travel or a community outbreak. […] The second dose of MMR may be given as early as 4 weeks after the first dose, and be counted as a valid dose, if both doses were given after the first birthday.
- #66 Mumps Treatment & Management: Approach Considerations, Inpatient Care, Consultations and Transferhttps://emedicine.medscape.com/article/966678-treatment
A single dose of vaccine in the volume specified by the manufacturer (standardly 0.5 mL) should be administered subcutaneously (SC). Although not routinely recommended, intramuscular (IM) vaccination is effective and safe. […] Immunoglobulin (IVIG) has not shown benefit to patients as treatment for post-exposure prophylaxis and hence, is not recommended. In the United States, mumps IVIG is no longer available or licensed for use. Vaccination post-exposure is not harmful and may possibly avert later disease. […] A study published in 2011 evaluated MMR vaccine effectiveness in persons who received 1 or 2 doses of this vaccine during a mumps outbreak that occurred between September 1, 2009 and June 10, 2010 in Ontario, Canada. […] Cardemil et al evaluated the effectiveness of a third dose of the MMR vaccine in a study that included 20,496 university students, of which 259 were diagnosed with mumps during an outbreak.
- #67 Mumps Treatment & Management: Approach Considerations, Inpatient Care, Consultations and Transferhttps://emedicine.medscape.com/article/966678-treatment
The third dose was associated with a 78.1% lower risk of mumps compared to the second dose at 28 days post vaccination. […] The live attenuated mumps vaccine is produced in chick embryo cell culture; hence persons with a history of anaphylactic reactions (i.e., hives, swelling of the mouth and throat, difficulty breathing, hypotension, shock) after egg product ingestion should be vaccinated with caution, using published protocols. […] Mumps vaccine does contain trace amounts of neomycin (25 mcg). As such, persons who have experienced anaphylactic reactions to topically or systemically administered neomycin should not receive the mumps vaccine.
- #68 2025 Measles Outbreak Guidancehttps://www.nmhealth.org/about/erd/ideb/mog/
Two doses of MMR vaccine provide the best protection against measles. […] The best way to prevent getting sick is to be immunized against measles. Two doses of the MMR (measles, mumps, rubella) vaccine are highly effective at preventing measles. […] The following public health offices will offer daily walk-in MMR vaccinations with no appointments needed until further notice: […] Amador Clinic staff in collaboration with the Department of Health will be providing MMR vaccine for children and qualifying adults. […] Fridays, May 23 and 30 from 1-4 p.m., the Santa Fe Public Office will be accepting walk-in MMR vaccinations with no appointment necessary. […] In addition to MMR vaccines, COVID-19 and flu vaccines are also available. […] MMR vaccinations are available at the Deming (Luna County) Public Health Office. […] 8 a.m. noon every Tuesday at the Albuquerque Midtown Public Health Office. […] The NMDOH Helpline can help you find local pharmacies with vaccine in stock, coordinate with public health offices to get you vaccinated and answer medical questions.
- #69 More measles cases in Victoria | health.vic.gov.auhttps://www.health.vic.gov.au/health-alerts/new-measles-case-in-victoria-4
Two doses of the measles-mumps-rubella (MMR) vaccine are required for immunity. […] The MMR vaccine is widely available at GPs and pharmacies. No Medicare card is required to get a state funded MMR vaccine. […] Free MMR vaccine is available under the National Immunisation Program and state-funded MMR program. No Medicare card is required to access free state funded MMR vaccine. […] Vaccination is the best way to protect yourself and others. Check if you’re protected against measles today. If you haven’t had two doses, or you don’t know, visit your GP or pharmacy for a catch-up MMR vaccine. […] Offer MMR vaccine to people born during or after 1966 who do not have documented evidence of receiving two doses of a measles-containing vaccine or documented evidence of immunity.
- #70 Measles – Diagnosis & treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/measles/diagnosis-treatment/drc-20374862
There’s no antiviral treatment for measles. But other kinds of well-researched treatments can help ease symptoms, lower the risk of complications and prevent death from measles. […] A healthcare professional may give children vitamin A as part of treatment for measles. The dose of vitamin A depends on the child’s age. Children with low levels of vitamin A who get measles are more likely to be very sick than are children with recommended levels. […] These treatments are well researched and help people with measles feel better, manage complications and prevent death. […] Other treatments for measles may have serious side effects and limited supporting evidence. For example, there is no clear benefit of steroid treatments of any kind. Steroid treatment may make measles worse in some people. In other situations, treatment may help only people at high risk of serious measles illness or those who are already very ill. A qualified healthcare professional can help you understand the risks and benefits based on your situation.
- #71https://abc7.com/what-is-measles-symptoms-treatment-how-are-treated/3965144/
Though a vaccination program has drastically reduced measles cases in the U.S., measles is still one of the leading causes of death in young children internationally, according to the World Health Organization. […] According to the Centers for Disease Control, there is no antiviral treatment specifically for measles. Rather, medical treatment is „supportive and to help relieve symptoms and address complications such as bacterial infections” while the virus runs its course, and symptoms often subside after several days. […] Getting the MMR vaccine within 72 hours of being exposed to measles may offer some protection against the disease, such as having a milder illness, according to the CDC. […] The MMR vaccine prevents measles in addition to mumps and rubella. The CDC recommends that children receive two MMR vaccinations; one when they are 12-15 months old and another when they are 4-6 years old. There is also an MMR vaccine available for adults.
- #72 Measles – Diagnosis & treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/measles/diagnosis-treatment/drc-20374862
There’s no antiviral treatment for measles. But other kinds of well-researched treatments can help ease symptoms, lower the risk of complications and prevent death from measles. […] A healthcare professional may give children vitamin A as part of treatment for measles. The dose of vitamin A depends on the child’s age. Children with low levels of vitamin A who get measles are more likely to be very sick than are children with recommended levels. […] These treatments are well researched and help people with measles feel better, manage complications and prevent death. […] Other treatments for measles may have serious side effects and limited supporting evidence. For example, there is no clear benefit of steroid treatments of any kind. Steroid treatment may make measles worse in some people. In other situations, treatment may help only people at high risk of serious measles illness or those who are already very ill. A qualified healthcare professional can help you understand the risks and benefits based on your situation.
- #73 Should You Get a Measles Vaccine Booster? > News > Yale Medicinehttps://www.yalemedicine.org/news/should-you-get-a-measles-vaccine-booster
The MMR vaccine is also safe, according to the CDC, which notes that most people have no side effects. […] The good news is that most people have immunity to measles either through immunization or previous infection, Dr. Roberts says. […] Anyone 6 months or older should be vaccinated if they are in an area where an outbreak is occurring. […] There is no specific antiviral therapy for measles, but medical care can help relieve symptoms and address complications.
- #74 Measles – Diagnosis & treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/measles/diagnosis-treatment/drc-20374862
There’s no antiviral treatment for measles. But other kinds of well-researched treatments can help ease symptoms, lower the risk of complications and prevent death from measles. […] A healthcare professional may give children vitamin A as part of treatment for measles. The dose of vitamin A depends on the child’s age. Children with low levels of vitamin A who get measles are more likely to be very sick than are children with recommended levels. […] These treatments are well researched and help people with measles feel better, manage complications and prevent death. […] Other treatments for measles may have serious side effects and limited supporting evidence. For example, there is no clear benefit of steroid treatments of any kind. Steroid treatment may make measles worse in some people. In other situations, treatment may help only people at high risk of serious measles illness or those who are already very ill. A qualified healthcare professional can help you understand the risks and benefits based on your situation.
- #75 Measles – Diagnosis & treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/measles/diagnosis-treatment/drc-20374862
There’s no antiviral treatment for measles. But other kinds of well-researched treatments can help ease symptoms, lower the risk of complications and prevent death from measles. […] A healthcare professional may give children vitamin A as part of treatment for measles. The dose of vitamin A depends on the child’s age. Children with low levels of vitamin A who get measles are more likely to be very sick than are children with recommended levels. […] These treatments are well researched and help people with measles feel better, manage complications and prevent death. […] Other treatments for measles may have serious side effects and limited supporting evidence. For example, there is no clear benefit of steroid treatments of any kind. Steroid treatment may make measles worse in some people. In other situations, treatment may help only people at high risk of serious measles illness or those who are already very ill. A qualified healthcare professional can help you understand the risks and benefits based on your situation.
- #76 Measles, Mumps and Rubella (MMR) – Fit for Travelhttps://www.fitfortravel.nhs.uk/advice/disease-prevention-advice/measles-mumps-and-rubella-mmr
Measles, mumps and rubella are viral infections which can be prevented by having the Measles, Mumps, Rubella (MMR) vaccine. […] MMR is the vaccine used in the UK. It is a combined vaccine that protects against measles, mumps and rubella. […] Two doses of measles, mumps and rubella (MMR) vaccine are needed in your life time to protect you against all three viruses. […] All three of these viral infections can be prevented by the MMR vaccine. […] There is no cure for measles, mumps or rubella. Most people usually recover at home without any treatment. You can treat symptoms at home by: […] If complications occur, you should seek medical advice as you may need to be admitted to hospital for treatment.
- #77 Mumps Treatment & Management: Approach Considerations, Inpatient Care, Consultations and Transferhttps://emedicine.medscape.com/article/966678-treatment
A single dose of vaccine in the volume specified by the manufacturer (standardly 0.5 mL) should be administered subcutaneously (SC). Although not routinely recommended, intramuscular (IM) vaccination is effective and safe. […] Immunoglobulin (IVIG) has not shown benefit to patients as treatment for post-exposure prophylaxis and hence, is not recommended. In the United States, mumps IVIG is no longer available or licensed for use. Vaccination post-exposure is not harmful and may possibly avert later disease. […] A study published in 2011 evaluated MMR vaccine effectiveness in persons who received 1 or 2 doses of this vaccine during a mumps outbreak that occurred between September 1, 2009 and June 10, 2010 in Ontario, Canada. […] Cardemil et al evaluated the effectiveness of a third dose of the MMR vaccine in a study that included 20,496 university students, of which 259 were diagnosed with mumps during an outbreak.
- #78 Measles, Mumps and Rubella (MMR) – Fit for Travelhttps://www.fitfortravel.nhs.uk/advice/disease-prevention-advice/measles-mumps-and-rubella-mmr
Measles, mumps and rubella are viral infections which can be prevented by having the Measles, Mumps, Rubella (MMR) vaccine. […] MMR is the vaccine used in the UK. It is a combined vaccine that protects against measles, mumps and rubella. […] Two doses of measles, mumps and rubella (MMR) vaccine are needed in your life time to protect you against all three viruses. […] All three of these viral infections can be prevented by the MMR vaccine. […] There is no cure for measles, mumps or rubella. Most people usually recover at home without any treatment. You can treat symptoms at home by: […] If complications occur, you should seek medical advice as you may need to be admitted to hospital for treatment.
- #79 Rubella (German Measles): Symptoms, Treatment & Preventionhttps://my.clevelandclinic.org/health/diseases/17798-rubella
How is rubella treated? […] The best way to prevent rubella is vaccination with the MMR (or MMRV) vaccine. […] Rubella vaccination can involve either the MMR or the MMRV vaccine. […] The MMR vaccine protects against measles, mumps and rubella. […] Most children and adults over the age of 12 can get vaccinated against rubella. […] If you plan to start a family, you should get vaccinated or tested for rubella antibodies at least one month before trying to get pregnant. […] The ways to treat congenital rubella syndrome depend on its severity. Some conditions are treatable with medication or surgery. Other damage is permanent, and its only possible to manage the condition to improve quality of life.
- #80 Measles vaccination: Know the factshttps://www.idsociety.org/public-health/measles/know-the-facts/
IDSA is committed to helping parents understand that the vaccine that prevents measles, mumps and rubella, or MMR, is safe, effective and protects the people you care about most. The MMR vaccine typically is given to children in two doses, one between 12 and 15 months old and the second between 4 and 6 years old. Two doses of MMR vaccine in childhood are about 97% effective at preventing measles, providing long-term and possibly lifelong immunity. […] Fact: The MMR vaccine does not cause autism. […] Fact: The MMR vaccine prevents serious illness and death. […] Since the vaccine, U.S. measles-related deaths have been rare because the vaccine has prevented people from getting measles in the first place. […] Fact: Getting the vaccine is much safer than getting the measles. […] There have been no deaths shown to be related to the MMR vaccine in healthy people. […] The MMR is a weakened live virus vaccine, also known as an attenuated vaccine.
- #81 MMR Vaccine (Measles, Mumps & Rubella Vaccination)https://my.clevelandclinic.org/health/procedures/mmr-vaccine
The MMR vaccine is highly effective at protecting you and your child against three serious viral infections: measles, mumps and rubella. […] The MMR vaccine can help prevent measles, mumps and rubella. These viral infections are all highly infectious conditions that can spread easily among people who arent vaccinated. […] The MMR vaccine is a weakened (attenuated) live virus. That means after you receive it, the viruses cause a harmless infection with few or no symptoms. Then, your body eliminates the viruses. Your immune system fights the infection that the weakened viruses cause, and your immunity to the viruses develops. […] The CDC recommends that children should receive two doses of the MMR vaccine. They should receive their first dose between 12 and 15 months old. They typically receive their second dose between 4 and 6 years old.
- #82 MMR vaccine – Wikipediahttps://en.wikipedia.org/wiki/MMR_vaccine
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles), abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection. […] The MMR vaccine is widely used around the world. As of 2012, 575 million doses had been administered since the vaccine’s introduction worldwide. Measles resulted in 2.6 million deaths per year before immunization became common. This has decreased to 122,000 deaths per year as of 2012, mostly in low-income countries. Through vaccination, as of 2018, rates of measles in North and South America are very low. Rates of disease have been seen to increase in populations that go unvaccinated. Between 2000 and 2018, vaccination decreased measles deaths by 73%.
- #83 LAC | DPH – Vaccine Preventable Disease Control Programhttp://publichealth.lacounty.gov/ip/diseases/measles/index.htm
Vaccination is the most effective way to prevent measles. […] Measles can be prevented by the measles-mumps-rubella (MMR) vaccine. […]
- #84https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-measles-vaccination
The influence of this paper, along with systemic misinformation by anti-vaccination groups in high-income countries, resulted in a drop in vaccination rates, below the level required for community protection, which caused a resurgence in measles cases in England and Wales, as well as parts of the USA and Canada. […] Because measles has such a high infectivity rate, the threshold for community protection is also very high, requiring at least 95% immunity among the population to prevent epidemics. […] The region of the Americas was declared free of endemic measles in 2016 by an independent body of experts, becoming the first WHO region to achieve this distinction of having eliminated measles. […] To address these issues, the Pan American Health Organization (PAHO, the WHO Regional Office for the Americas), has trained countries in rapid response to avoid measles and rubella virus spreading, improved surveillance, and launched renewed high-quality follow up vaccination campaigns.
- #85https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-measles-vaccination
The influence of this paper, along with systemic misinformation by anti-vaccination groups in high-income countries, resulted in a drop in vaccination rates, below the level required for community protection, which caused a resurgence in measles cases in England and Wales, as well as parts of the USA and Canada. […] Because measles has such a high infectivity rate, the threshold for community protection is also very high, requiring at least 95% immunity among the population to prevent epidemics. […] The region of the Americas was declared free of endemic measles in 2016 by an independent body of experts, becoming the first WHO region to achieve this distinction of having eliminated measles. […] To address these issues, the Pan American Health Organization (PAHO, the WHO Regional Office for the Americas), has trained countries in rapid response to avoid measles and rubella virus spreading, improved surveillance, and launched renewed high-quality follow up vaccination campaigns.
- #86https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-measles-vaccination
The influence of this paper, along with systemic misinformation by anti-vaccination groups in high-income countries, resulted in a drop in vaccination rates, below the level required for community protection, which caused a resurgence in measles cases in England and Wales, as well as parts of the USA and Canada. […] Because measles has such a high infectivity rate, the threshold for community protection is also very high, requiring at least 95% immunity among the population to prevent epidemics. […] The region of the Americas was declared free of endemic measles in 2016 by an independent body of experts, becoming the first WHO region to achieve this distinction of having eliminated measles. […] To address these issues, the Pan American Health Organization (PAHO, the WHO Regional Office for the Americas), has trained countries in rapid response to avoid measles and rubella virus spreading, improved surveillance, and launched renewed high-quality follow up vaccination campaigns.
- #87 With lower measles vaccine rates, some North Dakota counties may struggle with virus, experts say – InForum | Fargo, Moorhead and West Fargo news, weather and sportshttps://www.inforum.com/news/north-dakota/with-lower-measles-vaccine-rates-some-north-dakota-counties-may-struggle-with-virus-experts-say
FARGO â As fewer people in North Dakota vaccinate their children for measles, some counties, particularly in the west, may struggle with the contagious and fatal disease, health experts say. […] The state also has ordered students who donât have the measles, mumps and rubella (MMR) vaccination to be pulled from three Williston schools for 21 days, in accordance with state law. […] Public health officials recommend that 95% of the population be vaccinated to prevent widespread infection. North Dakotaâs rate is less than 90%, according to state data. […] The only treatment available for measles is supportive, which includes rest, hydration and pain control, Nagpal said. No treatment exists to directly treat the virus, and doctors have to let the illness run its course, he said. […] Itâs never too late to get the MMR vaccine, Nagpal said. It is most effective before exposure and takes about 14 days to go into effect, he said. […] The MMR vaccine is the most effective way to fight measles and is safe, Carson said. […] Howell advised people to weigh the risks associated with measles with the risk of vaccinations, which are low, she added.
- #88 Measles, mumps and rubellahttps://www.hse.ie/eng/health/immunisation/pubinfo/pcischedule/vpds/mmr/
The MMR vaccine is safe for most people. […] Yes – MMR vaccine can be given to children with a severe egg allergy. […] No. We know that vaccines dont cause autism. […] After getting the vaccine, your child may have discomfort, redness or swelling around the area where the injection was given. […] The vaccine works by stimulating the immune system to build up protection against these diseases. […] The full course of MMR vaccine offers good protection against measles for 99% of people, against rubella (German measles) for 99% of people and against mumps for 88% of people. […] The MMR vaccine does not shed, therefore there is no risk of spreading measles infection after vaccination. […] It is very important that every child receives the MMR vaccine on time so they are protected from measles, mumps and rubella disease.